Markets:

Overview

News

Currencies

International

Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

16.30 -0.41 (-2.45%)

Delayed Quote Updated: 11:40 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft ↗

August 19, 2026

Avita Medical (NASDAQ:RCEL) presented results from its PermeaDerm-I study, a randomized controlled trial evaluating PermeaDerm as temporary wound coverage following excision and before split-thickness...

Via MarketBeat

Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18% ↗

August 16, 2026

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the...

Via MarketBeat

Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds ↗

August 16, 2026

Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th...

Via MarketBeat

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Revenue exceeded $21.7 million with guidance raised to $86M–$89M for full year.

Via The Motley Fool

Topics Earnings

Avita Medical (NASDAQ:RCEL) Beats Q2 Estimates and Raises Full-Year Guidance ↗

August 06, 2026

Via Chartmill

AVITA Medical (NASDAQ:RCEL) Q1 2026 Revenue Beat Fails to Offset Wider Loss, Stock Still Rises on Outlook ↗

May 14, 2026

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 07, 2026

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out...

Via Benzinga

What's going on in today's session ↗

August 07, 2026

Via Chartmill

Which stocks are gapping on Friday? ↗

August 07, 2026

Via Chartmill

Avita Medical Q2 Earnings Call Highlights ↗

August 07, 2026

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio...

Via MarketBeat

Topics Earnings

AVITA Medical Inc (NASDAQ:RCEL) Reports Mixed Q4 2025 Results, Provides 2026 Guidance ↗

February 12, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 09, 2026

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics...

Via Benzinga

Avita (RCEL) Q1 2026 Earnings Call Transcript ↗

May 15, 2026

Avita (RCEL) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 15, 2026

Via Chartmill

Avita Medical Q1 Earnings Call Highlights ↗

May 14, 2026

Avita Medical (NASDAQ:RCEL) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand...

Via MarketBeat

Topics Earnings

AVITA Medical (RCEL) Q4 2025 Earnings Transcript ↗

February 12, 2026

AVITA Medical (RCEL) Q4 2025 Earnings Transcript

Via The Motley Fool

This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

November 20, 2025

Via Benzinga

AVITA Medical (NASDAQ:RCEL) Reports Mixed Q3 2025 Results, Cuts Revenue Outlook Amid Reimbursement Headwinds ↗

November 06, 2025

AVITA Medical's Q3 revenue missed estimates due to reimbursement headwinds, but the company improved cost control and secured key Medicare pricing.

Via Chartmill

AVITA Medical (RCEL) Q3 2025 Earnings Transcript ↗

November 06, 2025

AVITA Medical (RCEL) Q3 2025 Earnings Transcript

Via The Motley Fool

Top movers in Friday's session ↗

October 17, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 17, 2025

Via Benzinga

Top stock movements in today's session. ↗

October 17, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

October 17, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

October 17, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

October 17, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 17, 2025

Via Benzinga

Here are the top movers in Monday's session. ↗

September 15, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 15, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

September 15, 2025

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.